Literature DB >> 24339010

Radiosynthesis of 11-[(18) F]fluoroundecyltriphenylphosphonium (MitoF) as a potential mitochondria-specific positron emission tomography radiotracer.

L Li1, L Brichard, L Larsen, D K Menon, R A J Smith, M P Murphy, F I Aigbirhio.   

Abstract

Changes in the magnitude of the mitochondrial membrane potential occur in a range of important pathologies. To assess changes in membrane potential in patients, we set out to develop an improved mitochondria-targeted positron emission tomography probe comprising a lipophilic triphenylphosphonium cation attached to a fluorine-18 radionuclide via an 11-carbon alkyl chain, which is well-established to effectively transport to and localise within mitochondria. Here, we describe the radiosynthesis of this probe, 11-[(18) F]fluoroundecyl-triphenylphosphonium (MitoF), from no-carrier-added [(18) F]fluoride and a fully automated synthetic protocol to prepare it in good radiochemical yields (2-3 GBq at end-of-synthesis) and radiochemical purity (97-99%).
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  MitoF; PET; fluorine-18; imaging; mitochondria; triphenylphosphonium

Mesh:

Substances:

Year:  2013        PMID: 24339010     DOI: 10.1002/jlcr.3109

Source DB:  PubMed          Journal:  J Labelled Comp Radiopharm        ISSN: 0362-4803            Impact factor:   1.921


  2 in total

1.  New chemical and radiochemical routes to [18F]Rho6G-DEG-F, a delocalized lipophilic cation for myocardial perfusion imaging with PET.

Authors:  J A H Inkster; S Zhang; V Akurathi; A Belanger; S Dubey; T Treves; A B Packard
Journal:  Medchemcomm       Date:  2017-08-25       Impact factor: 3.597

Review 2.  Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.

Authors:  Jacek Zielonka; Joy Joseph; Adam Sikora; Micael Hardy; Olivier Ouari; Jeannette Vasquez-Vivar; Gang Cheng; Marcos Lopez; Balaraman Kalyanaraman
Journal:  Chem Rev       Date:  2017-06-27       Impact factor: 60.622

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.